Prostate cancer research

The HUS Comprehensive Cancer Center conducts research on a broad scale to promote the treatment of cancer and develop medication. Below is a list of all ongoing trials in which you can volunteer to participate. An updated list of trials is also available on the Nordic NECT website.

How to become a clinical trial participant?
You can be referred to a clinical trial by your physician. You can also contact the clinical trial unit’s nurse manager directly and they can give you information on how to become a clinical trial participant, and help with finding a suitable trial if one is available.


Contact Information:
haluantutkimuspotilaaksi@hus.fi
tel. +358 50 427 0680
 
 

Prostate cancer, ongoing trials

 
A randomized, double-blind, placebo-controlled phase III study of ODM-201 versus placebo inaddition to standard androgen deprivation therapy and docetaxel in patients with metastatic hormone-sensitive prostate cancer
The purpose of this study is to compare standard androgen deprivation therapy and the drug ODM-201 in combination with docetaxel to a placebo in patients with metastatic hormone-sensitive prostate cancer.